Conference

The start to finish of biologics

 

The Festival of Biologics brings together senior biologics professionals across the value chain to advance the industry to improve patient health.

We cover the start to finish of biologics: from discovery to development, to manufacturing and market access.

 

 

2023 Top Speakers...

Anne de Groot
CEO/CSO
Epivax
Anne de Groot speaking at Festival of Biologics Basel
Alain Beck
Senior Director, Biologics CMC and Developability, Pierre Fabre, Associate Editor
mAbs
Alain Beck speaking at Festival of Biologics Basel
Andreas Seidl
CSO
Formycon
Andreas Seidl speaking at Festival of Biologics Basel
Anita Seshire
Head of Laboratory in Exploratory Cancer Research
Merck
Anita Seshire speaking at Festival of Biologics Basel
Bert Thomas
Senior VP, Business Development
Bio-Thera
Bert Thomas speaking at Festival of Biologics Basel
Cecil Nick
VP, Biotechnology
PAREXEL
Cecil Nick speaking at Festival of Biologics Basel
Cecile Geuijen
CSO
Merus NV
Cecile Geuijen speaking at Festival of Biologics Basel
Christian Klein
Site Head
Roche Innovation Center Zurich
Christian Klein speaking at Festival of Biologics Basel
Fabio Baschiera
Global Clinical Leader Opthalmology
Bayer
Fabio Baschiera speaking at Festival of Biologics Basel
Hans Clevers
Head Roche Pharma Research and Early Development
Roche
Hans Clevers speaking at Festival of Biologics Basel
Lenka Sadilkova
Head of Preclinical Research and Development
MABLink
Lenka Sadilkova speaking at Festival of Biologics Basel
Michael Thiele
Chief Scientific Officer
OncoOne
Michael Thiele speaking at Festival of Biologics Basel
Michael Zaiac
Head of Oncology, Europe
Novartis
Michael Zaiac speaking at Festival of Biologics Basel
Mourad Rezk
VP, Global Head of Medical and Development (Biosimilars)
Biogen
Mourad Rezk speaking at Festival of Biologics Basel
Thomas Hach
Director of Healthcare Systems
Novartis
Thomas Hach speaking at Festival of Biologics Basel
Zoë Johnson
CSO
Affivant
Zoë Johnson speaking at Festival of Biologics Basel

 

 
  See All Our Speakers...
 
  BOOK TICKETS

Key topics on the agenda include: 

AI and Machine Learning in Oncology and Biomarkers
Antibodies in Immunotherapy
Armed Antibodies
Biosimilar Development, Manufacturing and Analysis
Biosimilars in Healthcare Policy
Checkpoint Inhibitors
Clinical Trials
CMC, Developability and Manufacturability
Commercialization and Market Access
Commercialization of Biosimilars and Sustainability of the Industry
Neoantigens
New Technology in Screening and Analytics for Antibody Proteins
Non-Oncology Immunotherapy
Novel Indications for Therapeutic Antibodies
Oncolytic Viruses
The Clinical Environment and Real-world Evidence
Tumor Microenvironment
Value and affordability of Biosimilars

 

BOOK YOUR PASS NOW